LI Qi, QI Zhi-Ye, XIAO Qun-Wen, HE Xiang-Ying, ZENG Jie, XU Jing.
Treatment of nephritic edema by torasemide in children[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(6): 520-521
中图分类号:
R725
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1]Vargas Hein O, Staegemann M, Wagner D, von Heymann C, Martin M, Morgera S, et al.Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients[J]. Ren Fail, 2005, 27(4): 385-392.
[2]De Haes A, Proost JH, De Baets MH, Stassen MH, Houwertjes MC, Wierda JM. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs[J].Anesthesiology, 2003, 98(1): 133-142.
[3]Van der Vorst MM, Kist JE, van der Heijden AJ, Burggraaf J.Diuretics in pediatrics: current knowledge and future prospects[J]. Pediatr Drugs, 2006, 8(4): 245-264.
[8]Doucet A, Favre G, Deschênes G. Molecular mechanism of edema formation in nephritic syndrome:theraeutic implications[J].Pediatr Nephrol, 2007, 22(12): 1983-1990.
[9]Blose JS, Adams KF Jr, Patterson JH. Torsemide: a pyridine-sulfonylurea loop diuretic[J]. Ann Pharmacother, 1995, 29(4): 396-402.